Conventional small molecule approaches have struggled to address genetic defects and complex disease mechanisms, leaving ...
Dr Reddy's Laboratories has received an establishment inspection report from the USFDA for its Srikakulam facility. The report classifies the site as 'Voluntary Action Indicated', meaning no immediate ...
Expands commercial readiness and diagnostic, manufacturing footprintAppoints new leadership in commercial strategy and technical ...
We are thrilled to welcome Adam and Ashley to the Climb Bio leadership team,” said Aoife Brennan, M.B., Ch.B., President and ...
SHELTON, CT / ACCESS Newswire / October 20, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), announced that its clinical lead drug NV-387 has shown strong ...
Teva and Prestige announce a license and supply agreement for the commercialization of Prestige’s Tuznue®, a biosimilar to Herceptin® (trastuzumab) Tuznue® received European Commission (EC) marketing ...
Detailed price information for Aspire Biopharma Holdings Inc (ASBP-Q) from The Globe and Mail including charting and trades.
Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the ...
Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for ...